Home ›
Trademark Categories ›
Pharmaceuticals ›
2007 ›
GY ›
GYBAXIM
Trademark search for:
GYBAXIM
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2007-11-13 — Application filed
2007-12-13 — Limitation of goods/services from ib entered
2007-12-13 — Sn assigned for sect 66a appl from ib
2007-12-14 — Application filed
2008-02-01 — Assigned to examiner
2008-02-12 — Final disposition recorded
2008-02-13 — Office action issued
2008-02-13 — Office action issued
2008-02-13 — Office action issued
2008-03-17 — Attorney/dom.rep.revoked and/or appointed
2008-03-17 — Examiners amendment -written
2008-03-17 — Approved for pub - principal register
2008-03-17 — Examiner's amendment entered
2008-03-17 — Teas revoke/app/change addr of atty/dom rep received
2008-03-18 — Examiners amendment mailed
2008-03-28 — Office action issued
2008-03-29 — Assigned to lie
2008-03-29 — Law office publication review completed
2008-04-16 — Notice of publication
2008-05-06 — Published for opposition
2008-07-22 — Registered-principal register
2008-10-23 — Final disposition recorded
2008-11-14 — Final disposition recorded
2008-11-14 — Final disposition recorded
2008-12-26 — Final disposition recorded
2009-06-19 — Teas change of correspondence received
2013-02-23 — Change of name/address rec'd from ib
2013-04-12 — New representative at ib received
2015-02-27 — Cancelled section 71
2015-10-27 — Total invalidation of reg ext protection created
2015-12-22 — Invalidation processed
2015-12-28 — Total invalidation of reg ext protection sent to ib
2016-01-22 — Total invalidation processed by the ib
2017-11-13 — Final status recorded
2018-06-08 — Death of international registration
2018-06-08 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
Novartis AG
CH
NOVARTIS AG
CH
NOVARTIS AG
CH
Correspondent
Maury M. Tepper, III Tepper & Eyster, PLLC 3724 Benson Drive Raleigh, NC 27609 UNITED STATES
Filing Details
Filing Date:
2007-11-13
Status Date:
2017-11-13
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.